Simplex Trading’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-4,574
Closed -$1.45M 10250
2023
Q4
$1.45M Buy
+4,574
New +$889K ﹤0.01% 2651
2023
Q3
Sell
-100
Closed -$18.8K 10179
2023
Q2
$21K Buy
+100
New +$21.4K ﹤0.01% 6756
2023
Q1
Sell
-7,232
Closed -$1.38M 10461
2022
Q4
$1.42M Buy
7,232
+174
+2% +$37.3K ﹤0.01% 2143
2022
Q3
$1.59M Buy
7,058
+6,908
+4,605% +$1.4M ﹤0.01% 2176
2022
Q2
$18K Buy
+150
New +$17.2K ﹤0.01% 7740
2021
Q1
Sell
-7,943
Closed -$900K 10318
2020
Q4
$0 Buy
+7,943
New +$736K ﹤0.01% 9275
2020
Q3
Sell
-504
Closed -$42.9K 8725
2020
Q2
$0 Sell
504
-1,762
-78% -$153K ﹤0.01% 8573
2020
Q1
$163K Buy
+2,266
New +$194K ﹤0.01% 3827

Simplex Trading's KRTX Position: Q1 2024 in Review

Simplex Trading sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 4,574 shares — an estimated $1.45M sold.

Simplex Trading first reported a position in KRTX in Q1 2020 and held it in 8 quarters. The position peaked at $1.59M in Q3 2022. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Simplex Trading reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Simplex Trading sold 4,574 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $1.45M.
  • Simplex Trading first reported a position in Karuna Therapeutics, Inc. Common Stock in Q1 2020 and held it in 8 quarters.
  • Simplex Trading's Karuna Therapeutics, Inc. Common Stock position peaked at $1.59M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Simplex Trading's 13F filing for Q1 2024, filed 25 Apr 2024.